Vitaccess

We are a patient-centered research organization. At Vitaccess, we redefine the landscape of real-world evidence (RWE) generation through our groundbreaking Vitaccess RealTM platform. Powering your studies, our platform and our expert team enable you to gain deeper and faster insights into the impact of diseases and treatments in the real world. We are: Specialists in Real-World Primary Data Collection: We design and run studies collecting data directly from patients, caregivers, and clinicians, ensuring full study management. Patient-Centric: We prioritize multi-stakeholder co-creation with patient groups and clinical experts, ensuring an inclusive methodology and patient-relevant data collection. Our patient-centric research can help...

Market access,real-world evidence,byod,epro,heor,rare diseases,melanoma,charcot marie tooth,localization,migraine,health economics,oncology,analytics,data,myasthenia gravis,orphan,cystic fibrosis,alsp,pcor,and healthcare research

Vitaccess operates in the Biotechnology research industry.

Vitaccess's revenue is 11m - 100m

Vitaccess has 11 - 50 employees.